SignatureFD’s 20/20 Biolabs Inc AIDX Stock Holding History

SignatureFD’s Portfolio AIDX Stock Details AIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$335	Hold	767	–	–	﹤0.01%	3450
2026 Q2	$422	Buy	+767	New	+$963	﹤0.01%	3380

Other funds holding AIDX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

McDonald Partners Cleveland, Ohio $423M AUM 27.93% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

SignatureFD's AIDX Position: Q3 2026 in Review

SignatureFD held its 20/20 Biolabs Inc (AIDX) position steady in Q3 2026 at 767 shares worth $335. The position accounts for ﹤0.01% of the portfolio, ranked #3450.

SignatureFD first reported a position in AIDX in Q2 2026 and has held it in 2 quarters since. The position peaked at $422 in Q2 2026. 5 funds tracked by Wall St. Rank hold AIDX as of Q3 2026.

SignatureFD held 767 shares of 20/20 Biolabs Inc worth $335 as of Q3 2026.
SignatureFD left its 20/20 Biolabs Inc share count unchanged in Q3 2026.
20/20 Biolabs Inc made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3450 holding.
SignatureFD first reported a position in 20/20 Biolabs Inc in Q2 2026 and has held it in 2 quarters since.
SignatureFD's 20/20 Biolabs Inc position peaked at $422 in Q2 2026.
5 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.